Welcome back, Jane. You're in Week 4 of your Recovery & Pain protocol. Your latest check-in shows continued improvement. How can I help?

BPC-157 (Body Protection Compound-157) is a pentadecapeptide that promotes healing through several mechanisms: it upregulates growth factor receptors, promotes angiogenesis (new blood vessel formation), and modulates the nitric oxide system. In animal models, it has demonstrated accelerated healing of tendons, ligaments, muscles, and even the GI tract. However, large-scale human clinical trials are still limited — most evidence comes from preclinical research and clinical observation.

Your hs-CRP went from 2.8 mg/L to 0.8 mg/L — that's a significant reduction in systemic inflammation. While BPC-157 and TB-500 both have documented anti-inflammatory properties, we can't definitively attribute the entire reduction to the protocol alone. Other factors like sleep improvement (your sleep quality score went from 5 to 7), increased physical activity, and general recovery all contribute. That said, the timeline correlates well with your protocol start, and this pattern is consistent with what we see in other Recovery & Pain participants.